key: cord-0977000-qvyfwwbs
authors: Walters, William; Collins, Tim; Evans, Alys
title: The additional cost in PPE to NHS services during Covid-19: a review of the expense incurred by Aneurin Bevan Healthboards Maxillofacial unit over a 1 year period to meet current clinical guidelines
date: 2020-08-19
journal: Br J Oral Maxillofac Surg
DOI: 10.1016/j.bjoms.2020.08.072
sha: 0dcb2cf3c4125b2ce1f280d9595f6b27d53c4299
doc_id: 977000
cord_uid: qvyfwwbs

Covid-19 has lead to increased levels of personal protective equipment (PPE) in surgical specialties. Aneurin Bevan Healthboard Oral and Maxillofacial unit sees approximately 2808 patients per annum and to meet current guidelines this added PPE is estimated to cost and extra £32,292. Whilst this helps improve safety for clinicians and patients we also recommend evidence is regularly reviewed to assess what PPE is justified at different stages of viral prevalence.

The aim of this project is to highlight the additional cost of this PPE to NHS services during Covid-19. As a profession it is incumbent on us to regularly review evidence in order to assess what PPE is justified at different stages of viral prevalence.

Data was taken retrospectively from Aneurin Bevan Healthboard to assess how many clinical procedures were carried out over a one year period. This was then multiplied by the additional cost of PPE required due to Covid-19 to estimate an overall cost. Choice of The added cost of PPE due to current Covid-19 guidelines totaled £11.50 per patient.

Multiplied by 2808 patients the total cost of a 1-year period was £32,292.

Guidelines from governing bodies have a widespread impact on clinicians in both primary and secondary care settings. The aim is to provide treatment whilst maximizing safety for both patients and clinicians. Cost should not be a disproportionate driving factor when guidelines are written, however the likely long term effects of Covid-19 means that this financial burden will be significant. As such, all guidelines should be founded on a strong evidence base that should be regularly reviewed though the various stages of the pandemic. This will help reduce the likelihood of unnecessary use of PPE where there is no appreciable clinical benefit, whilst improving cost efficiencies.

A conservative estimate of increased PPE expenditure for the forthcoming year is £32,292 for Aneurin Bevan Maxillofacial unit. This is likely to increase significantly as wholesale PPE costs rise. The expenditure is needed to reduce Covid-19 transmission whilst continuing to provide surgical treatment. To reduce this ongoing cost all must be done to help reduce viral spread ensuring normal clinical standards can return as soon as possible. 

and designated urgent dental care provider site guidelines. British Association of Oral and Maxillofacial Surgeons

Personal protective equipment and Covid 19-a risk to healthcare staff?

Precaution of 2019 novel coronavirus infection in department of oral and maxillofacial surgery

Provision of Emergency Maxillofacial Service During the COVID-19 Pandemic : A Collaborative Five Centre UK. British Journal of Oral and Maxillofacial Surgery